Dassault Systèmes: H1 EPS up 10%
(CercleFinance.com) - In line with its preliminary announcement, Dassault Systèmes is reporting non-IFRS EPS of E0.
60 for H1 2024, up 10% at constant exchange rates, with a non-IFRS operating margin of 30.5% vs. 31% in H1 2023.
Also at constant exchange rates, total sales rose 5% to E3bn, including software sales that rose 5% to E2.7bn, an amount now 82% formed from recurring revenues.
Dassault Systèmes also confirms its adjusted outlook for 2024, expecting total sales growth of 6% to 8%, an operating margin of 32% to 32.4% and EPS growth of between 8% and 11%.
In addition, the group reports that Eisai has chosen Medidata Clinical Data Studio, its recently announced AI-based solution, to monitor its clinical data, facilitate clinical trial execution and enhance the patient experience.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
60 for H1 2024, up 10% at constant exchange rates, with a non-IFRS operating margin of 30.5% vs. 31% in H1 2023.
Also at constant exchange rates, total sales rose 5% to E3bn, including software sales that rose 5% to E2.7bn, an amount now 82% formed from recurring revenues.
Dassault Systèmes also confirms its adjusted outlook for 2024, expecting total sales growth of 6% to 8%, an operating margin of 32% to 32.4% and EPS growth of between 8% and 11%.
In addition, the group reports that Eisai has chosen Medidata Clinical Data Studio, its recently announced AI-based solution, to monitor its clinical data, facilitate clinical trial execution and enhance the patient experience.
Copyright (c) 2024 CercleFinance.com. All rights reserved.